These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10640241)

  • 1. [Neuroprotective activity of angiotensin-converting enzyme inhibitors during cerebral ischemia].
    Kozhevnikova EV; Adzhienko LM
    Biull Eksp Biol Med; 1999 Nov; 128(11):535-7. PubMed ID: 10640241
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats.
    Ghazi-Khansari M; Mohammadi-Karakani A; Sotoudeh M; Mokhtary P; Pour-Esmaeil E; Maghsoud S
    J Appl Toxicol; 2007; 27(4):342-9. PubMed ID: 17265423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril and enalapril: angiotensin-converting enzyme inhibitors.
    Allen TA; Wilke WL; Fettman MJ
    J Am Vet Med Assoc; 1987 Jan; 190(1):94-6. PubMed ID: 3028998
    [No Abstract]   [Full Text] [Related]  

  • 6. [New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
    Fortschr Med Suppl; 1988; 48():1-11. PubMed ID: 2904396
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuation of focal cerebral ischemic injury following post-ischemic inhibition of angiotensin converting enzyme (ACE) activity in normotensive rat.
    Panahpour H; Dehghani GA
    Iran Biomed J; 2012; 16(4):202-8. PubMed ID: 23183619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Do we need more ACE inhibitors?].
    Haugen O
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1411. PubMed ID: 2187274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitors of the conversion enzyme and glycoregulation].
    Richard JL; Ferrière M; Bringer J; Mirouze J
    Diabete Metab; 1990; 16(3):265-6. PubMed ID: 2210026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic effect of captopril and enalapril in young rats.
    Buczko W; Kubik A; Kucharewicz I; Chabielska E
    Pol J Pharmacol; 2004; 56(1):97-104. PubMed ID: 15047983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
    Ribuot C; Rochette L
    Cardiovasc Drugs Ther; 1987; 1(1):51-5. PubMed ID: 2856461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic effect of captopril and enalapril in old rats.
    Chabielska E; Mogielnicki A; Kramkowski K; Buczko W
    Pharmacol Rep; 2005; 57(1):135-7. PubMed ID: 15849389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.